Shares of Isis Pharmaceuticals (Nasdaq:ISIS) were gapping up Monday morning with an open price 13.2% higher than Friday's closing price. The stock closed at $21.99 yesterday and opened today's trading at $24.90.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Shares of Isis Pharmaceuticals (Nasdaq: ISIS) were gapping up Monday morning with an open price 13.2% higher than Friday's closing price. The stock closed at $21.99 Friday and opened today's trading at $24.90.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The average volume for Isis has been 1.4 million shares per day over the past 30 days. Isis has a market cap of $2.35 billion and is part of the health care sector and drugs industry. Shares are up 110.6% year to date as of the close of trading on Friday. Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. TheStreet Ratings rates Isis as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. You can view the full Isis Ratings Report. Get more investment ideas from our investment research center. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..